Contact
searchSearch
HMP Global

Volume 20 - Issue 10 - October 2023

Column

Editor's Corner
Atherectomy in the Infrainguinal Arteries
10/30/2023
McCall Walker, MD; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP; Sahil A. Parikh, MD, FACC, FSCAI; Matthew T. Finn, MD, MS
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports...
10/30/2023
Vascular Disease Management

Feature

Original Research
Mechanical and Pharmacological Treatment of Symptomatic Acute Portomesenteric Venous Thrombosis Through a TIPS Tract
10/30/2023
Santhosh Reddy Kantala, MD, FNVIR; Ashish Goel, DM, MD; C.E. Eapen, MD, DM; Santhosh Babu Bharathy, MD, MBBS; Uday George Zachariah, MBBS, MD, DM, FRCP; Vinu Moses, MD, DNB, MBBS; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the technical feasibility, long-term patency rate, and clinical outcome in patients who presented with symptomatic acute portomesenteric thrombosis and were treated with mechanical thrombectomy and pharmacological...
The authors evaluate the...
10/30/2023
Vascular Disease Management

Insights

Interview
When Is the VenaSeal Closure System Appropriate for Patients With Ulcers and Combined Arterial and Venous Disease?
10/30/2023
Michael Shao, MD
Michael Shao, MD, RVPI, discusses his presentation at AMP 2023 about the VenaSeal closure system and when it is appropriate for use in combined arterial and venous disease.
Michael Shao, MD, RVPI, discusses his presentation at AMP 2023 about the VenaSeal closure system and when it is appropriate for use in combined arterial and venous disease.
Michael Shao, MD, RVPI,...
10/30/2023
Vascular Disease Management
Interview
Overcoming Barriers to Implementation of VOYAGER Results Into Everyday Practice
10/30/2023
R. Kevin Rogers, MD, MSc, RPVI
Dr. Rogers provides insight into the barriers that may be preventing clinicians from implementing VOYAGER-PAD findings into everyday practice.
Dr. Rogers provides insight into the barriers that may be preventing clinicians from implementing VOYAGER-PAD findings into everyday practice.
Dr. Rogers provides insight into...
10/30/2023
Vascular Disease Management
Video
Darren Schneider, MD, Reviews Key Outcomes and Implications of 5-Year IDE Data for Iliac Branch Device
10/01/2023
Darren Schneider, MD
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider discusses impact to perceptions on whether to sacrifice or preserve the hypogastric artery based on key outcomes from 5-year IDE data.
Watch as Dr. Darren Schneider...
10/01/2023
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

October 2023 Volume 20 Issue 10

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use